BodyScan (BDYS) Price & Analysis

Q: What was BodyScan Corp.’s price range in the past 12 months?

BodyScan Corp. lowest stock price was <$0.01 and its highest was $0.01 in the past 12 months.

Q: What is BodyScan Corp.’s market cap?

BodyScan Corp.’s market cap is $819.00.

Q: When is BodyScan Corp.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

Q: Is BodyScan Corp. overvalued?

According to Wall Street analysts BodyScan Corp.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: Does BodyScan Corp. pay dividends?

BodyScan Corp. does not currently pay dividends.

Q: What is BodyScan Corp.’s EPS estimate?

BodyScan Corp.’s EPS estimate for its next earnings report is not yet available.

Q: How many shares outstanding does BodyScan Corp. have?

BodyScan Corp. has 818,766,050 shares outstanding.

Q: Which hedge fund is a major shareholder of BodyScan Corp.?

Currently, no hedge funds are holding shares in BDYS

Q: What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

24 Followers

BDYS Stock Chart & Stats

$0.01

>-$0.01(-95.00%)

At close: May 14 4:00 PM EDT

$0.01

>-$0.01(-95.00%)

Day’s Range― - ―

52-Week Range<$0.01 - $0.01

Previous CloseN/A

Volume200.00

Average Volume (3M)N/A

Market Cap

$819.00

Enterprise ValueN/A

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta16.10

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding818,766,050

10 Day Avg. VolumeN/A

30 Day Avg. VolumeN/A

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market Cap0.00

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

BDYS FAQ

What was BodyScan Corp.’s price range in the past 12 months?

BodyScan Corp. lowest stock price was <$0.01 and its highest was $0.01 in the past 12 months.

What is BodyScan Corp.’s market cap?

BodyScan Corp.’s market cap is $819.00.

When is BodyScan Corp.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were BodyScan Corp.’s earnings last quarter?

Currently, no data Available

Is BodyScan Corp. overvalued?

According to Wall Street analysts BodyScan Corp.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does BodyScan Corp. pay dividends?

BodyScan Corp. does not currently pay dividends.

What is BodyScan Corp.’s EPS estimate?

BodyScan Corp.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does BodyScan Corp. have?

BodyScan Corp. has 818,766,050 shares outstanding.

What happened to BodyScan Corp.’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of BodyScan Corp.?

Currently, no hedge funds are holding shares in BDYS

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

BodyScan Corp.

Based in Irvine, California, BodyScan Corp. specializes in providing advanced medical diagnostic imaging. They utilize state-of-the-art GE-Imatron Electron Beam Tomography (EBT) technology to detect a range of conditions, including coronary artery disease (CAD), various pulmonary ailments, neoplastic growths, and calculi.